Recurrent GBS With COVID-19 in a Child: A Case Report

Akçay, Nihal; Oğur, Mustafa; Menentoğlu, Mehmet Emin; Sofuoğlu, Ayşe İrem; Işik, İlhan; Şevketoğlu, Esra

doi:10.1097/inf.0000000000003809

Cited by 2 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, these two factors were also general risk factors for COVID-19 [ 60 ] and mortality due to this disease [ 61 ]. Nonetheless, cases of GBS associated with COVID-19 in children have also been described [ 59 , 62 , 63 , 64 , 65 ].…”

Section: Covid-19 and Guillain–barre Associationmentioning

confidence: 99%

The Impact of COVID-19 on the Guillain–Barré Syndrome Incidence

Kopańko,

Zabłudowska,

Zajkowska

et al. 2024

Biomedicines

View full text Add to dashboard Cite

Despite the fact that the global COVID-19 pandemic has officially ended, we continue to feel its effects and discover new correlations between SARS-CoV-2 infection and changes in the organism that have occurred in patients. It has been shown that the disease can be associated with a variety of complications, including disorders of the nervous system such as a characteristic loss of smell and taste, as well as less commonly reported incidents such as cranial polyneuropathy or neuromuscular disorders. Nervous system diseases that are suspected to be related to COVID-19 include Guillain–Barré syndrome, which is frequently caused by viruses. During the course of the disease, autoimmunity destroys peripheral nerves, which despite its rare occurrence, can lead to serious consequences, such as symmetrical muscle weakness and deep reflexes, or even their complete abolition. Since the beginning of the pandemic, case reports suggesting a relationship between these two disease entities have been published, and in some countries, the increasing number of Guillain–Barré syndrome cases have also been reported. This suggests that previous contact with SARS-CoV-2 may have had an impact on their occurrence. This article is a review and summary of the literature that raises awareness of the neurological symptoms’ prevalence, including Guillain–Barré syndrome, which may be impacted by the commonly occurring COVID-19 disease or vaccination against it. The aim of this review was to better understand the mechanisms of the virus’s action on the nervous system, allowing for better detection and the prevention of its complications.

show abstract